AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Some Obese Postmenopausal Women Impervious to Metabolic Disturbances.

Women's Health Weekly

| May 24, 2001 | COPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 MAY 24 - (NewsRx Network) -- by N.R. Saltmarsh, staff medical writer -- A subset of postmenopausal women, despite being obese, are apparently able to avoid the metabolic disturbances such as insulin resistance often associated with obesity.

These women were more likely to have become obese at a younger age and less likely to have visceral body fat compared with obese women with metabolic abnormalities, wrote M. Brochu and colleagues in the Journal of Clinical Endocrinology and Metabolism.

"It is unclear why some obese individuals fail to show traditional risk factors associated with the insulin resistance syndrome despite having a very high accumulation of body fat," said Brochu and associates. "To address this issue, we identified and studied a subgroup of metabolically normal but obese (MNO) postmenopausal women to gain insight into potential physiological factors that may protect them against the development of obesity-related co-morbidities."

Brochu and team studied the metabolic characteristics of 43 obese, sedentary, post-menopausal women, 17 were MNO and 26 were metabolically abnormal obese (MAO), as determined by insulin resistance.

Although the two groups had similar body fat percentages (45.2% [+ or -] 5.3% versus 44.8% [+ or -] 6.6%) MNO subjects had 49% less visceral adipose tissue than MAO subjects. The researchers found no differences in abdominal subcutaneous tissue, total fat mass, muscle weakness, or physical activity energy expenditure.

Other findings were as follows:

* MNO subjects had lower fasting plasma glucose and insulin levels and lower insulin levels during the oral glucose tolerance test but similar two-hour glucose levels ...

Related articles from newspapers, magazines, journals, and more
Health issues in postmenopausal women who drink.
Magazine article from: Alcohol Research & Health Register, Thomas C. Cline, J. Mark Shively, Carol A. December 22, 2002 700+ words
...these three diseases in postmenopausal women. The authors stress...potential health effects in postmenopausal women should be interpreted...and well. being of postmenopausal women through the direct...
FDA Approves Lilly's Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The...
Press release article from: PR Newswire September 14, 2007 700+ words
...reduce invasive breast cancer risk in postmenopausal women with osteoporosis INDIANAPOLIS...breast cancer in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast...
FDA Advisory Committee Recommends Approval of EVISTA for the Reduction of Risk...
Press release article from: PR Newswire July 24, 2007 700+ words
...provide an important option for postmenopausal women at increased risk for breast cancer...cancer risk in two populations: postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...
ARZOXIFENE LIFTS BMD IN POSTMENOPAUSAL WOMEN BETTER THAN EVISTA.
News wire article from: AsiaPulse News March 24, 2009 700+ words
...raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis ATHENS, Mar 23...Turnover Markers versus Raloxifene in Postmenopausal Women with Osteoporosis Eli Lilly and...and treatment of osteoporosis in postmenopausal women and the reduction of risk of invasive...
Novartis Launches Z-FAST: A Study Evaluating Femara(R) and Zometa(R) in...
Press release article from: PR Newswire December 10, 2002 700+ words
...treatment-related bone loss in postmenopausal women with early breast cancer Novartis...associated with cancer treatment in postmenopausal women with early breast cancer. The Novartis...benefit from this information -- postmenopausal women receiving aromatase inhibitor therapy...
Special Feature: Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs...
Magazine article from: OB/GYN Clinical Alert January 1, 2004 700+ words
...Feature Unilocular Ovarian Cysts in Postmenopausal Women: Surgery vs Expectant Management...and required surgical resection. Postmenopausal women werent supposed to have ovarian...evidence that the vast majority of postmenopausal women with unilocular ovarian cysts up...
Eli Lilly and Company Submits New Drug Application for EVISTA for Reduction of...
Press release article from: PR Newswire December 7, 2006 700+ words
...risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for breast cancer...and prevention of osteoporosis in postmenopausal women. "If approved, EVISTA would be...
Lilly's Evista Associated with Significant Reduction of Cardiovascular Events...
Press release article from: Business Wire February 19, 2002 700+ words
...risk of cardiovascular events in postmenopausal women participating in an osteoporosis...and treatment of osteoporosis in postmenopausal women. Evista is currently being studied...related events and breast cancer in postmenopausal women. The four-year cardiovascular...
For more facts and information, see all results

Source: HighBeam Research, Some Obese Postmenopausal Women Impervious to Metabolic Disturbances.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA